TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Clinical trial NCT01090648 · COMPLETED
Trial details
- NCT number
- NCT01090648
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.